Drug intelligence / Profile preview

Oral GLP-1

Development stage
Preclinical
Lead developer
Biora Therapeutics
Modality
Peptides
Administration
Oral
01

Overview

Oral GLP-1 (Biora Therapeutics) is an oral drug-device combination candidate that utilizes Biora Therapeutics' (formerly Progenity) PGTx/OBDS (Oral Biotherapeutics Delivery System) platform to deliver a glucagon-like peptide-1 (GLP-1) receptor agonist. The OBDS is an autonomous, ingestible capsule designed to navigate the gastrointestinal tract and trigger delivery in the small intestine. Upon activation, the device uses a needle-free liquid jet to inject the biologic payload directly into the submucosal layer of the intestinal wall, bypassing gastric degradation and achieving systemic bioavailability comparable to subcutaneous injection. The GLP-1 component acts as an agonist at the GLP-1 receptor, stimulating insulin secretion, inhibiting glucagon release, and slowing gastric emptying, which are key mechanisms for managing type 2 diabetes and obesity. This technology aims to provide a more convenient oral alternative to traditional injectable biologics.

Other names
GLP-1 (OBDS)Oral GLP-1 (Progenity)glucagon-like peptide-1 + PGTx
02

Targets

Beyond the preview

Go deeper on Oral GLP-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oral GLP-1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call